findmyKOL

Barry Borlaug, MD

Enriched profile

Professor of Medicine; Director, Circulatory Failure Research, Division of Cardiovascular Diseases; Chair for Research, Division of Circulatory Failure, Department of Cardiovascular Medicine · Mayo Clinic

ORCIDNPI
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiovascular Function and Risk Factors+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2016–2026

Barry Borlaug is Professor of Medicine; Director, Circulatory Failure Research, Division of Cardiovascular Diseases; Chair for Research, Division of Circulatory Failure, Department of Cardiovascular Medicine at Mayo Clinic. OpenAlex indexes 826 publications with 55,517 citations (h-index 120); ClinicalTrials.gov lists 25 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Advanced Heart Failure and Transplant Cardiology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 27 Aug 2026

Barry A. Borlaug, MD, is Professor of Medicine at Mayo Clinic, Rochester, MN. The public record shows 826 publications with 55,517 citations (h-index 120), centered on Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Pulmonary Hypertension Research and Treatments. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 10 companies, 4 NIH-funded awards (2016–2026).

  • Most recent indexed publication: 2026 · Circulation. Heart failure
  • Top research focus: Cardiovascular Function and Risk Factors
  • 25 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure21 trialsPulmonary Hypertension3 trialsHypertension3 trialsDyspnea2 trialsHeart Failure, Diastolic1 trialObesity1 trialMyocarditis1 trialPericarditis1 trialPericarditis, Constrictive1 trial

Research focus

OpenAlex concept fingerprint
Cardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementPulmonary Hypertension Research and TreatmentsCardiovascular and exercise physiologyCardiac Valve Diseases and Treatments

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trialsIndustry payments8Publications1Mounjarogeneric · TirzepatideClinical trialsIndustry payments2Publications4

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trialsIndustry payments45Mayo ClinicClinical trials19Industry paymentsBoehringer Ingelheim International GmbHClinical trialsIndustry payments12

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
826publications

Distinct works indexed by OpenAlex, matched via ORCID; 93 in PubMed.

55,517citations

Total citations across indexed works.

120h-index

Hirsch index (OpenAlex). i10-index 400.

Clinical & industry

trials, payments and federal funding
25clinical trials

Investigator role on registered studies.

View trials
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
4NIH grants · 2016–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    SGLT2 inhibitor100%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

4 NIH research awards on record, funded 20162026 per NIH RePORTER. The latest:

13 more award records behind the reveal.Reveal →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/barry-borlaug-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Barry-Borlaug

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • X / Twitter

    x.com/bborlaugmd

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com

Mentions by others

where others cite or feature them
  • Other

    medprofvideos.mayoclinic.org/participant/barry-borlaug-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medprofvideos.mayoclinic.org
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Guest Editor

    Circulation: Heart Failure (AHA/ASA Journals)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ahajournals.org
  • Active member/presenter

    Heart Failure Society of America (HFSA); co-lead author, HFSA scientific statement on heart failure with mildly reduced ejection fraction

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hfsa.org

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.